Online information center provides free access to the latest medical and scientific information from across Elsevier’s global research content, platforms, and clinical resources.

Elsevier, a scientific publisher and global information analytics business specializing in science and health, has launched a Monkeypox Information Center.

The hub will be continually updated and provide free access to relevant research and clinical information on the Monkeypox virus from across Elsevier’s scientific and medical journals and clinical resources for healthcare professionals.

This research and health information will be freely available from Elsevier platforms and shared with the World Health Organization (WHO).

In addition, the company will contribute Monkeypox-relevant journal articles to PubMed Central, the archive of biomedical and life sciences research in the U.S. National Institutes of Health’s National Library of Medicine, for as long as the Monkeypox public health emergency is ongoing.

The Monkeypox Information Center will offer access to journal articles and book chapters to ensure researchers, clinicians and the public can readily discover relevant content from the rapidly growing body of literature.

It will also provide a machine-readable corpus to enable the use of text and data mining technologies to identify patterns and relationships in data, as countries around the world address this global public health crisis.

The Monkeypox Information Center is updated continuously with the latest research information on the virus and the disease.

Monkeypox-related journal articles and book chapters are made freely available on ScienceDirect, Elsevier’s global platform of peer-reviewed scholarly literature. Around 400 journal articles were identified initially, and the latest research and guidance will be added as they become available.

The launch of this information center is part of Elsevier’s commitment to supporting research and healthcare communities in their efforts to address public health emergencies and follows the company’s information hubs for Ebola, SARS, Zika, and MERS outbreaks, and the current pandemic response continues to be supported by the existing novel coronavirus resource center.

Photo 248170390 © Planetfelicity |